Stockreport

XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF Business development : Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics [Read more]